Artificial Retina Market Size, Share, Growth, Trends, and Global Industry Analysis: By Implant Type (Epiretinal Implants, Subretinal Implants), By Disease Type (Retinitis Pigmentosa, Age-related Macular Degeneration, Others), By End Users (Hospitals, Clinics, Ambulatory Surgical Centers), and Region

Artificial Retina Market size was valued at US$ 21,125.6 million in 2023 and is poised to grow at a CAGR of 20.2% from 2024-2030. An artificial retina is a medical device consists an array of microelectrodes. Artificial Retina Market is implanted into the eyes of people who are blind due to retinal disease. These devices are used in retinal degenerative disease that causes damage to photoreceptor cells of the retina and leads to complete vision loss. Majorly occurring retinal degenerative diseases include retinitis pigmentosa and age-related macular degeneration. Retinal implants are made up of carbon nanotube biomimetic film with a transmitter and video processing units. These devices restore vision by capturing light, convert into electrical signals, and form an image by stimulating the neurons in the retina. Impact of COVID-19 on With the expanding number of COVID-19 diseases universally, limitations on various developments in the Artificial Retina Market are expanding.

As the worldwide economy battles with the pandemic circumstance, its effect on the worldwide exchange and store network is becoming inferable from the quick debilitating of worldwide speculation streams. Severe regulation measures forced by administrations of different nations and preventive measures to control the impact of the incidence have prompted a critical limitation in transportation, driving a thump on impact internationally. This is encouraging an interest and supply hole, consequently bringing about diminished creation of stress help supplements. This pattern is required to keep inferable from the vulnerability in the Artificial Retina Market and measures to address the inventory/request lop-sidedness.